查找临床试验

已按「免疫性血小板减少症」检索,对应国际通用词 immune thrombocytopenia

试验不在中国怎么办?

共找到 12 项正在招募的试验(在中国/港澳台设有中心)

数据更新于 11:18,每 5 分钟自动同步
正在招募I 期 / II 期中国有中心NCT06721013

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

United States、China、Denmark、France、Italy 等 10 国

年龄 18 Years不限

Eli Lilly and Company

正在招募早期 I 期中国有中心NCT06519565

Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)

China

年龄 18 Years不限

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

正在招募III 期中国有中心NCT07559331

High-Dose Dexamethasone Combined With Orelabrutinib Versus High-Dose Dexamethasone Combined With Placebo in Adult Patients With Newly Diagnosed Primary Immune Thrombocytopenia

China

年龄 18 Years80 Years

Shandong University

正在招募I 期 / II 期中国有中心NCT06853444

A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia

China

年龄 18 Years不限

Shanghai Escugen Biotechnology Co., Ltd

正在招募II 期中国有中心NCT04993885

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

China

年龄 18 Years不限

Institute of Hematology & Blood Diseases Hospital, China

正在招募II 期中国有中心NCT06838949

A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP

China

年龄 60 Years不限

Institute of Hematology & Blood Diseases Hospital, China

正在招募II 期中国有中心NCT06478537

TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination

China

年龄 18 Years50 Years

Peking Union Medical College Hospital

正在招募I 期中国有中心NCT06880081

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

China

年龄 18 Years65 Years

Chongqing Peg-Bio Biopharm Co., Ltd.

正在招募II 期中国有中心NCT07294365

A Study of DZD8586 in Adults With Primary Immune Thrombocytopenia (ITP) (TAI-SHAN11)

China

年龄 18 Years不限

Dizal Pharmaceuticals

正在招募II 期中国有中心NCT06799611

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

China

年龄 18 Years不限

Institute of Hematology & Blood Diseases Hospital, China

正在招募II 期中国有中心NCT05199909

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

China

年龄 18 Years不限

Institute of Hematology & Blood Diseases Hospital, China

正在招募早期 I 期中国有中心NCT06888960

Safety Study of CC312 in Autoimmune Disease Patients

China

年龄 18 Years不限

CytoCares Inc